Hosted on MSN1mon
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The 503A pharmacies make compounded drugs according to individual prescriptions for a specific patient and are largely regulated by states rather than the FDA. Meanwhile, pharmacies manufacturing ...
FiercePharma26d
Lilly looks to 'protect its interests' by moving to join FDA lawsuit over compounded tirzepatide
The company warned that compounded versions of tirzepatide ... The company argued that following a $23 billion manufacturing scale-up campaign, all doses of Mounjaro and Zepbound have been ...
FiercePharma25d
Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row
Novo has made similar claims about the challenges of Victoza manufacturing in the past ... to the FDA’s Demonstrable Difficulties for Compounding lists, citing complexities around formulations ...
ET Auto5d
'Semicon project to be ready in 3 years'
Odisha Semiconductor Policy: "Odisha will manufacture for global markets and create significant technical and other ...